Leaflet: information for the user
Pregabalina Zentiva 25mg hard EFG capsules
Pregabalina Zentiva 50mg hard EFG capsules
Pregabalina Zentiva 75mg hard EFG capsules
Pregabalina Zentiva 100mg hard EFG capsules
Pregabalina Zentiva 150mg hard EFG capsules
Pregabalina Zentiva 200mg hard EFG capsules
Pregabalina Zentiva 225mg hard EFG capsules
Pregabalina Zentiva 300mg hard EFG capsules
pregabalina
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
Pregabalina Zentiva belongs to a group of medications used for the treatment of epilepsy, neuropathic pain, and generalized anxiety disorder (GAD) in adults.
Neuropathic pain
Pregabalina Zentiva is used for the treatment of chronic pain caused by nerve damage. There are various diseases that can cause peripheral neuropathic pain, such as diabetes or herpes. The pain sensation can be described as heat, burning, pulsating pain, stabbing pain, acute pain, spasms, continuous pain, tingling, numbness, and pins and needles sensation. Peripheral and central neuropathic pain may also be associated with mood changes, sleep disturbances, fatigue (tiredness), and can affect physical and social activity and overall quality of life.
Epilepsy
Pregabalina Zentiva is used in the treatment of certain types of epilepsy (partial seizures with or without secondary generalization) in adults. Your doctor will prescribe Pregabalina Zentiva to treat epilepsy when your current treatment does not control the disease. You must take Pregabalina Zentiva in addition to your current treatment. Pregabalina Zentiva should not be administered alone, but always used in combination with other antiepileptic treatments.
Generalized anxiety disorder
Pregabalina Zentiva is used in the treatment of generalized anxiety disorder (GAD). GAD symptoms include excessive and prolonged anxiety and worry that are difficult to control. GAD can also produce restlessness or feeling of excitement or nervousness, feeling easily fatigued (tired), difficulty concentrating or mind going blank, irritability, muscle tension, or sleep disturbances. This is different from everyday stress and tension.
Do not take Pregabalina Zentiva
Warnings and precautions
Consult your doctor or pharmacist before starting to take Pregabalina Zentiva.
Children and adolescents
The safety and efficacy of pregabalin have not been established in children and adolescents (under 18 years) and therefore pregabalin should not be used in this age group.
Use of Pregabalina Zentiva with other medicines
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine.
Pregabalina Zentiva can be taken with oral contraceptives.
Taking Pregabalina Zentiva with food, drinks, and alcohol
Pregabalina Zentiva capsules can be taken with and without food.
It is recommended not to take alcohol during treatment with Pregabalina Zentiva.
Pregnancy and breastfeeding
You should not take Pregabalina Zentiva during pregnancy or lactation, unless your doctor has told you to. You should use an effective contraceptive method in women of childbearing age. If you are pregnant or breastfeeding, or think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medicine.
Driving and operating machinery
Pregabalin may cause dizziness, somnolence, and decreased concentration. You should not drive, operate heavy machinery, or engage in other potentially hazardous activities until you know if this medicine affects your ability to perform these activities.
Pregabalina Zentiva contains lactose monohydrate
If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medicine.
Follow exactly the administration instructions of this medication as indicated by your doctor.
In case of doubt, consult your doctor or pharmacist again.
Your doctor will determine the appropriate dose for you.
Pregabalina Zentiva is exclusively for oral use.
Neuropathic pain periphery and central, epilepsy or generalized anxiety disorder
Take the number of hard capsules as indicated by your doctor.
The dose, which has been adjusted for you and your condition, will generally be between 150 mg and 600 mg per day.
Your doctor will instruct you to take Pregabalina Zentiva two or three times a day. In the case of twice a day, take Pregabalina Zentiva once in the morning and once at night, approximately at the same time every day. In the case of three times a day, take Pregabalina Zentiva in the morning, at noon, and at night, approximately at the same time every day.
If you estimate that the action of Pregabalina Zentiva is too strong or too weak, inform your doctor or pharmacist.
If you are an elderly patient (over 65 years old), you should take Pregabalina Zentiva normally, except if you have kidney problems.
Your doctor may prescribe another dosing regimen and/or different doses if you have kidney problems.
Swallow the entire capsule with water.
Continue taking Pregabalina Zentiva until your doctor tells you to stop.
If you take more Pregabalina Zentiva than you should
Call your doctor or go to the nearest emergency service immediately. Bring the Pregabalina Zentiva hard capsules box with you. As a result of taking more Pregabalina Zentiva than you should, you may feel drowsy, confused, agitated, or restless. Seizures have also been reported.
If you forgot to take Pregabalina Zentiva
It is essential to take Pregabalina Zentiva capsules regularly at the same time every day. If you forget to take a dose, take it as soon as you remember, unless it is time for the next dose. In that case, continue with the next dose normally. Do not take a double dose to compensate for the missed doses.
If you interrupt the treatment with Pregabalina Zentiva
Do not stop taking Pregabalina Zentiva unless your doctor tells you to. If you are going to stop treatment, this should be done gradually over a minimum of one week.
Once the treatment with Pregabalina Zentiva is completed, whether short-term or long-term, you should know that you may experience certain adverse effects. These include insomnia, headaches, nausea, anxiety symptoms, diarrhea, flu-like symptoms, seizures, nervousness, depression, pain, sweating, and dizziness. These symptoms may appear more frequently or severely if you have been taking pregabalin for a longer period.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
If you experience swelling in the face or tongue, or if your skin becomes red and develops blisters or peeling, you should seek immediate medical attention.
Certain side effects, such as drowsiness, may be more frequent since patients with spinal cord injury may be taking other medications to treat, for example, pain or spasticity (tense or rigid muscles), with side effects similar to those of pregabalin, so the intensity of these side effects may increase when taken together.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through thenational notification system included in theAppendix V. By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not store at a temperature above 30°C.
Do not use this medication after the expiration date that appears on the blister and carton after the letters “CAD/EXP”. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the medications that you no longer need. This will help protect the environment.
Composition of Pregabalina Zentiva
The active ingredient ispregabalin. Each hard capsule contains 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg or 300mg of pregabalin.
The other components are lactose monohydrate, pregelatinized cornstarch, talc, titanium dioxide (E171), gelatin, Shellac lacquer, iron oxide black (E172).
The 50mg capsules also contain propylene glycol, strong ammonia solution, potassium hydroxide.
The 25mg, 75mg, 100mg, 150mg, 200mg, 225mg, and 300mg capsules also contain polyethylene glycol.
The 75mg, 100mg, 200mg, 225mg, and 300mg capsules also contain iron oxide red (E172) and iron oxide yellow (E172).
Appearance of Pregabalina Zentiva and packaging contents | |
25mg capsules | Light grey cap and light grey body; approx. 15.9mm in length, hard gelatin capsule printed with “25”, containing a nearly white powder. |
50mg capsules | Light grey cap and light grey body; approx. 14.3mm in length, hard gelatin capsule printed with “50”, containing a nearly white powder. |
75mg capsules | Red cap and light grey body; approx. 14.3mm in length, hard gelatin capsule printed with “75”, containing a nearly white powder. |
100mg capsules | Red cap and red body; approx. 15.9mm in length, hard gelatin capsule printed with “100”, containing a nearly white powder. |
150mg capsules | Light grey cap and light grey body; approx. 18.0mm in length, hard gelatin capsule printed with “150”, containing a nearly white powder. |
200mg capsules | Light beige cap and light beige body; approx. 19.4mm in length, hard gelatin capsule printed with “200”, containing a nearly white powder. |
225mg capsules | Light beige cap and light grey body; approx. 19.4mm in length, hard gelatin capsule printed with “225”, containing a nearly white powder. |
300mg capsules | Red cap and light grey body; approx. 21.7mm in length, hard gelatin capsule printed with “300”, containing a nearly white powder. |
Pregabalina Zentiva 25mg hard capsules are packaged in alu-alu blister (OPA/alu/PVC/alu) as primary packaging.
Pregabalina Zentiva 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, and 300mg hard capsules are packaged in PVC/alu blister as primary packaging.
Pregabalina Zentiva 25mg and 50mg are available in packaging sizes of 14, 21, 56, 84, 98, and 100 hard capsules.
Pregabalina Zentiva 75mg, 150mg, 225mg, and 300mg are available in packaging sizes of 14, 56, 98, and 100 hard capsules.
Pregabalina Zentiva 100mg and 200mg are available in packaging sizes of 21, 84, 98, and 100 hard capsules.
Only some packaging sizes may be marketed.
Marketing Authorization Holder
Zentiva, k.s.
U Kabelovny 130
102 37 Prague 10
Czech Republic
Responsible for manufacturing
Zentiva, k.s.
U Kabelovny 130
102 37 Prague 10
Czech Republic
or
S.C. Zentiva, S.A.
B-dul Theodor Pallady nr.50, sector 3, Bucharest, cod 032266
Romania
For more information about this medicinal product, please contact the local representative of the marketing authorization holder:
België/Belgique/Belgien Zentiva, k.s. Tel/Tel: +32280 86420 | Lietuva Zentiva, k.s. Tel:+370 52152025 |
???????? Zentiva, k.s. ???:+ 359 2805 72 08 | Luxembourg/Luxemburg Zentiva, k.s. Tel/Tel: +352208 82330 |
Czech Republic Zentiva, k.s. Tel: +420 267 241111 | Magyarország Zentiva, k.s. Tel.: +36165 55722 |
Danmark Zentiva, k.s. Tlf: +45787 68 400 | Malta Zentiva, k.s. Tel: +356277 82052 |
Deutschland Zentiva Pharma GmbH Tel: +49 (0) 800 53 53 010 | Nederland Zentiva, k.s. Tel: +31202253638 |
Eesti Zentiva, k.s. Tel: +372 52 70308 | Norge Zentiva, k.s. Tlf:+47219 66203 |
Ελλ?δα Zentiva, k.s. Τηλ: +30211198 7510 | Österreich Zentiva, k.s. Tel: +43720778877 |
España Zentiva, k.s. Tel: +34931815250 | Polska Zentiva Polska Sp. z o.o. Tel: + 48 22 375 92 00 |
France Zentiva France Tél: +33 (0) 800 089219 | Portugal Zentiva Portugal, Lda Tel: +351210601360 |
Hrvatska Zentiva, k.s. Tel: +385155 17772 | România ZENTIVA S.A. Tel: +40 021.304.7597 |
Ireland Zentiva, k.s. Tel: +353766803944 | Slovenija Zentiva, k.s. Tel: +386360 00408 |
Ísland Zentiva, k.s. Sími: +354539 0650 | Slovenská republika Zentiva, a.s. Tel: +421 2 3918 3010 |
Italia Zentiva Italia S.r.l. Tel: +39-02-38598801 | Suomi/Finland Zentiva, k.s. Puh/Tel: +358942598648 |
Κ?προς Zentiva, k.s. Τηλ: +357240 30144 | Sverige Zentiva, k.s. Tel:+46840838822 |
Latvija Zentiva, k.s. Tel: +371 67893939 | United Kingdom Zentiva Pharma UK Limited Tel:+44 (0) 845 372 7101 |
Last update of this leaflet:
Other sources of information
The detailed information on this medicinal product is available on the website of the European Medicines Agency:http://www.ema.europa.eu.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.